GUT MYCOBIOME IN THE SPECTRUM OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): FROM MASH TO HEPATOCELLULAR CARCINOMA Cassio Marques Perlin; Melina Keingeski Belén; Bruno de Souza Basso; Beatriz Mendes Borba; Julliane Dutra Medeiros; Francis Moreira Borges; Bernd Schnabl; Mario Reis Alvares-da-Silva;

ATORVASTATIN AND RIFAXIMIN IN THYROID PREVENT LIVER THYROID METABOLISM ABNORMALITIES IN HEPATOCELLULAR CARCINOMA: IN VITRO AND IN VIVO STUDY Bruno de Souza Basso; Thaliane Carvalho de Oliveira; Rachel Pinto Dornelles; Daiane Dias Cabeleira; Elisa Carolina Lange; Cristiane Gisele Gomes; Emanuela Tureta Cagnini; Luca Prá Scherer; Henrique Mombach Barreto; Leonardo Priesnitz Friedrich; Gustavo Santos Lucca; Maria Alice Smielevski Gomes; Carolina Fischer Nadvorny; Jessica Sindo; Maria Ines Gonzales Solari; Patricia Bencke Grudzinski; Laura Alvarez; Ezequiel Ridruejo; Simone Macagnin Wajner; Mario Reis Alvares-da-Silva;

Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;